Differential anti-APOBEC3G activity of HIV-1 Vif proteins derived from different subtypes

Yukie Iwabu, Masanobu Kinomoto, Masashi Tatsumi, Hideaki Fujita, Mari Shimura, Yoshitaka Tanaka, Yukihito Ishizaka, David Nolan, Simon Mallal, Tetsutaro Sata, Kenzo Tokunaga

研究成果: ジャーナルへの寄稿記事

32 引用 (Scopus)

抄録

Antiretroviral cytidine deaminase APOBEC3G, which is abundantly expressed in peripheral blood lymphocytes and macrophages, strongly protects these cells against HIV-1 infection. The HIV-1 Vif protein overcomes this antiviral effect by enhancing proteasome-mediated APOBEC3G degradation and is key for maintaining viral infectivity. The 579-bp-long vif gene displays high genetic diversity among HIV-1 subtypes. Therefore, it is intriguing to address whether Vif proteins derived from different subtypes differ in their viral defense activity against APOBEC3G. Expression plasmids encoding Vif proteins derived from subtypes A, B, C, CRF01-AE, and CRF02-AG isolates were created, and their anti-APOBEC3G activities were compared. Viruses produced from cells expressing APOBEC3G and Vif proteins from different subtypes showed relatively different viral infectivities. Notably, subtype C-derived Vif proteins tested had the highest activity against APOBEC3G that was ascribed to its increased binding activity, for which the N-terminal domain of the Vif protein sequences was responsible. These results suggest that the biological differences of Vif proteins belonging to different subtypes might affect viral fitness and quasispecies in vivo.

元の言語英語
ページ(範囲)35350-35358
ページ数9
ジャーナルJournal of Biological Chemistry
285
発行部数46
DOI
出版物ステータス出版済み - 11 12 2010

Fingerprint

vif Gene Products
HIV-1
vif Genes
Cytidine Deaminase
Lymphocytes
Macrophages
Proteasome Endopeptidase Complex
Viruses
HIV Infections
Antiviral Agents
Human immunodeficiency virus 1 vif protein
Plasmids
Blood
Genes
Cells
Degradation

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Molecular Biology
  • Cell Biology

これを引用

Iwabu, Y., Kinomoto, M., Tatsumi, M., Fujita, H., Shimura, M., Tanaka, Y., ... Tokunaga, K. (2010). Differential anti-APOBEC3G activity of HIV-1 Vif proteins derived from different subtypes. Journal of Biological Chemistry, 285(46), 35350-35358. https://doi.org/10.1074/jbc.M110.173286

Differential anti-APOBEC3G activity of HIV-1 Vif proteins derived from different subtypes. / Iwabu, Yukie; Kinomoto, Masanobu; Tatsumi, Masashi; Fujita, Hideaki; Shimura, Mari; Tanaka, Yoshitaka; Ishizaka, Yukihito; Nolan, David; Mallal, Simon; Sata, Tetsutaro; Tokunaga, Kenzo.

:: Journal of Biological Chemistry, 巻 285, 番号 46, 12.11.2010, p. 35350-35358.

研究成果: ジャーナルへの寄稿記事

Iwabu, Y, Kinomoto, M, Tatsumi, M, Fujita, H, Shimura, M, Tanaka, Y, Ishizaka, Y, Nolan, D, Mallal, S, Sata, T & Tokunaga, K 2010, 'Differential anti-APOBEC3G activity of HIV-1 Vif proteins derived from different subtypes', Journal of Biological Chemistry, 巻. 285, 番号 46, pp. 35350-35358. https://doi.org/10.1074/jbc.M110.173286
Iwabu, Yukie ; Kinomoto, Masanobu ; Tatsumi, Masashi ; Fujita, Hideaki ; Shimura, Mari ; Tanaka, Yoshitaka ; Ishizaka, Yukihito ; Nolan, David ; Mallal, Simon ; Sata, Tetsutaro ; Tokunaga, Kenzo. / Differential anti-APOBEC3G activity of HIV-1 Vif proteins derived from different subtypes. :: Journal of Biological Chemistry. 2010 ; 巻 285, 番号 46. pp. 35350-35358.
@article{1d2e666e416d48a08b5b1274e268ce12,
title = "Differential anti-APOBEC3G activity of HIV-1 Vif proteins derived from different subtypes",
abstract = "Antiretroviral cytidine deaminase APOBEC3G, which is abundantly expressed in peripheral blood lymphocytes and macrophages, strongly protects these cells against HIV-1 infection. The HIV-1 Vif protein overcomes this antiviral effect by enhancing proteasome-mediated APOBEC3G degradation and is key for maintaining viral infectivity. The 579-bp-long vif gene displays high genetic diversity among HIV-1 subtypes. Therefore, it is intriguing to address whether Vif proteins derived from different subtypes differ in their viral defense activity against APOBEC3G. Expression plasmids encoding Vif proteins derived from subtypes A, B, C, CRF01-AE, and CRF02-AG isolates were created, and their anti-APOBEC3G activities were compared. Viruses produced from cells expressing APOBEC3G and Vif proteins from different subtypes showed relatively different viral infectivities. Notably, subtype C-derived Vif proteins tested had the highest activity against APOBEC3G that was ascribed to its increased binding activity, for which the N-terminal domain of the Vif protein sequences was responsible. These results suggest that the biological differences of Vif proteins belonging to different subtypes might affect viral fitness and quasispecies in vivo.",
author = "Yukie Iwabu and Masanobu Kinomoto and Masashi Tatsumi and Hideaki Fujita and Mari Shimura and Yoshitaka Tanaka and Yukihito Ishizaka and David Nolan and Simon Mallal and Tetsutaro Sata and Kenzo Tokunaga",
year = "2010",
month = "11",
day = "12",
doi = "10.1074/jbc.M110.173286",
language = "English",
volume = "285",
pages = "35350--35358",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "46",

}

TY - JOUR

T1 - Differential anti-APOBEC3G activity of HIV-1 Vif proteins derived from different subtypes

AU - Iwabu, Yukie

AU - Kinomoto, Masanobu

AU - Tatsumi, Masashi

AU - Fujita, Hideaki

AU - Shimura, Mari

AU - Tanaka, Yoshitaka

AU - Ishizaka, Yukihito

AU - Nolan, David

AU - Mallal, Simon

AU - Sata, Tetsutaro

AU - Tokunaga, Kenzo

PY - 2010/11/12

Y1 - 2010/11/12

N2 - Antiretroviral cytidine deaminase APOBEC3G, which is abundantly expressed in peripheral blood lymphocytes and macrophages, strongly protects these cells against HIV-1 infection. The HIV-1 Vif protein overcomes this antiviral effect by enhancing proteasome-mediated APOBEC3G degradation and is key for maintaining viral infectivity. The 579-bp-long vif gene displays high genetic diversity among HIV-1 subtypes. Therefore, it is intriguing to address whether Vif proteins derived from different subtypes differ in their viral defense activity against APOBEC3G. Expression plasmids encoding Vif proteins derived from subtypes A, B, C, CRF01-AE, and CRF02-AG isolates were created, and their anti-APOBEC3G activities were compared. Viruses produced from cells expressing APOBEC3G and Vif proteins from different subtypes showed relatively different viral infectivities. Notably, subtype C-derived Vif proteins tested had the highest activity against APOBEC3G that was ascribed to its increased binding activity, for which the N-terminal domain of the Vif protein sequences was responsible. These results suggest that the biological differences of Vif proteins belonging to different subtypes might affect viral fitness and quasispecies in vivo.

AB - Antiretroviral cytidine deaminase APOBEC3G, which is abundantly expressed in peripheral blood lymphocytes and macrophages, strongly protects these cells against HIV-1 infection. The HIV-1 Vif protein overcomes this antiviral effect by enhancing proteasome-mediated APOBEC3G degradation and is key for maintaining viral infectivity. The 579-bp-long vif gene displays high genetic diversity among HIV-1 subtypes. Therefore, it is intriguing to address whether Vif proteins derived from different subtypes differ in their viral defense activity against APOBEC3G. Expression plasmids encoding Vif proteins derived from subtypes A, B, C, CRF01-AE, and CRF02-AG isolates were created, and their anti-APOBEC3G activities were compared. Viruses produced from cells expressing APOBEC3G and Vif proteins from different subtypes showed relatively different viral infectivities. Notably, subtype C-derived Vif proteins tested had the highest activity against APOBEC3G that was ascribed to its increased binding activity, for which the N-terminal domain of the Vif protein sequences was responsible. These results suggest that the biological differences of Vif proteins belonging to different subtypes might affect viral fitness and quasispecies in vivo.

UR - http://www.scopus.com/inward/record.url?scp=78149246959&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78149246959&partnerID=8YFLogxK

U2 - 10.1074/jbc.M110.173286

DO - 10.1074/jbc.M110.173286

M3 - Article

C2 - 20833716

AN - SCOPUS:78149246959

VL - 285

SP - 35350

EP - 35358

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 46

ER -